Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Jade Biosciences, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 81
- +18 vs. Q4 2023
- Shares held
- 28.5M
- +282.4K (+1.0%) vs. Q4 2023
- Total value
- $841.5M
- +$203.9M (+32.0%) vs. Q4 2023
- New holders
- 22
- 19 more added
- Sold out
- 4
- 23 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,263,982 | $244.4M | 3.11% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,758,686 | $111.1M | 6.56% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 2,201,274 | $65.1M | 5.15% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $60.3M | 5.57% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,680,517 | $49.7M | 0.62% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 1,204,867 | $35.6M | 1.50% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,069,796 | $31.6M | 1.39% | −141,900−11.7% | Reduced |
| Great Point Partners LLC | 887,690 | $26.2M | 4.09% | −150,000−14.5% | Reduced |
| Driehaus Capital Management LLC | 794,992 | $23.5M | 0.23% | −263,217−24.9% | Reduced |
| BlackRock Inc. | 709,752 | $21.0M | 0.00% | −17,702−2.4% | Reduced |
| Vanguard Group Inc | 672,275 | $19.9M | 0.00% | +45,444+7.2% | Added |
| OrbiMed Advisors LLC | 565,374 | $16.7M | 0.33% | −191,556−25.3% | Reduced |
| FMR LLC | 537,530 | $15.9M | 0.00% | +440.0% | Added |
| Eventide Asset Management, LLC | 445,500 | $13.2M | 0.21% | +433,322+3,558.2% | Added |
| Octagon Capital Advisors LP | 403,685 | $11.9M | 1.45% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 399,824 | $11.8M | 0.03% | −41,650−9.4% | Reduced |
| Ikarian Capital, LLC | 367,965 | $10.9M | 2.96% | +367,965 | New |
| Geode Capital Management, LLC | 281,760 | $8.33M | 0.00% | +4,865+1.8% | Added |
| Ensign Peak Advisors, Inc | 262,257 | $7.75M | 0.01% | +140,000+114.5% | Added |
| State Street Corp | 229,986 | $6.80M | 0.00% | +15,959+7.5% | Added |
| Ghost Tree Capital, LLC | 225,000 | $6.65M | 2.14% | +15,000+7.1% | Added |
| Woodline Partners LP | 200,000 | $5.91M | 0.05% | +200,000 | New |
| Superstring Capital Management LP | 110,264 | $3.26M | 2.16% | +110,264 | New |
| Northern Trust Corp | 98,559 | $2.91M | 0.00% | −968−1.0% | Reduced |
| Exome Asset Management LLC | 98,485 | $2.91M | 2.49% | +98,485 | New |
| Boothbay Fund Management, LLC | 97,842 | $2.89M | 0.09% | +97,842 | New |
| Nantahala Capital Management, LLC | 91,188 | $2.70M | 0.26% | 00.0% | Unchanged |
| Millennium Management LLC | 62,555 | $1.85M | 0.00% | +62,555 | New |
| Walleye Capital LLC | 54,520 | $1.61M | 0.02% | +54,520 | New |
| Eversept Partners, LP | 54,150 | $1.60M | 0.12% | +3,908+7.8% | Added |
| Nan Fung Group Holdings Ltd | 47,936 | $1.42M | 1.31% | 00.0% | Unchanged |
| Skandinaviska Enskilda Banken AB (publ) | 44,320 | $1.31M | 0.01% | −6,546−12.9% | Reduced |
| Fred Alger Management, LLC | 43,790 | $1.29M | 0.01% | +7,312+20.0% | Added |
| Nuveen Asset Management, LLC | 40,047 | $1.18M | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 30,958 | $915.4K | 0.00% | +1,416+4.8% | Added |
| Bank of New York Mellon Corp | 27,664 | $818.0K | 0.00% | −8,894−24.3% | Reduced |
| Morgan Stanley | 26,283 | $777.2K | 0.00% | −8,769−25.0% | Reduced |
| Shay Capital LLC | 24,588 | $727.1K | 0.21% | +24,588 | New |
| Two Sigma Investments, LP | 22,913 | $677.5K | 0.00% | +13,153+134.8% | Added |
| Prelude Capital Management, LLC | 20,685 | $611.7K | 0.04% | +20,685 | New |
| Alps Advisors Inc | 19,519 | $577.2K | 0.00% | +801+4.3% | Added |
| Parkwood LLC | 17,728 | $524.0K | 0.06% | +1,942+12.3% | Added |
| D. E. Shaw & Co., Inc. | 17,265 | $510.5K | 0.00% | +17,265 | New |
| ADAR1 Capital Management, LLC | 15,900 | $470.2K | 0.13% | +15,900 | New |
| Dimensional Fund Advisors LP | 14,957 | $442.3K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 14,622 | $432.4K | 0.00% | +465+3.3% | Added |
| Takeda Pharmaceutical Co Ltd | 13,580 | $401.6K | 0.14% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 13,100 | $387.4K | 0.00% | 00.0% | Unchanged |
| PDT Partners, LLC | 12,680 | $374.9K | 0.04% | +12,680 | New |
| Jane Street Group, LLC | 11,264 | $333.1K | 0.00% | −1,842−14.1% | Reduced |
| UBS Group AG | 11,237 | $332.3K | 0.00% | −1,004−8.2% | Reduced |
| Jump Financial, LLC | 9,600 | $283.9K | 0.01% | +9,600 | New |
| Bank of America Corp | 8,917 | $263.7K | 0.00% | −13,781−60.7% | Reduced |
| Barclays PLC | 7,872 | $232.8K | 0.00% | −7,522−48.9% | Reduced |
| Two Sigma Advisers, LP | 7,800 | $230.6K | 0.00% | +7,800 | New |
| Renaissance Technologies LLC | 7,500 | $222.0K | 0.00% | +7,500 | New |
| American Century Companies Inc | 7,124 | $210.7K | 0.00% | +7,124 | New |
| American International Group, Inc. | 5,509 | $162.9K | 0.00% | −47−0.8% | Reduced |
| MetLife Investment Management | 5,228 | $154.6K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 4,779 | $141.3K | 0.00% | −206−4.1% | Reduced |
| Quest Partners LLC | 4,626 | $136.8K | 0.02% | +4,626 | New |
| JPMorgan Chase & Co | 4,591 | $135.8K | 0.00% | −2,885−38.6% | Reduced |
| New York State Common Retirement Fund | 4,312 | $127.5K | 0.00% | +9+0.2% | Added |
| Wells Fargo & Company | 3,362 | $99.4K | 0.00% | +448+15.4% | Added |
| EntryPoint Capital, LLC | 3,126 | $92.4K | 0.08% | −3,007−49.0% | Reduced |
| Citigroup Inc | 2,547 | $75.3K | 0.00% | +452+21.6% | Added |
| STRS Ohio | 2,200 | $65.0K | 0.00% | −100−4.3% | Reduced |
| Tower Research Capital LLC (TRC) | 2,060 | $60.9K | 0.00% | +1,138+123.4% | Added |
| Legal & General Group Plc | 1,177 | $34.8K | 0.00% | −489−29.4% | Reduced |
| California State Teachers Retirement System | 1,124 | $33.2K | 0.00% | −716−38.9% | Reduced |
| Ameritas Investment Partners, Inc. | 772 | $22.8K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 701 | $20.7K | 0.00% | 00.0% | Unchanged |
| Fortitude Family Office, LLC | 416 | $12.3K | 0.01% | 00.0% | Unchanged |
| Amalgamated Bank | 347 | $10.0K | 0.00% | −1,085−75.8% | Reduced |
| Royal Bank of Canada | 287 | $8.00K | 0.00% | −3,188−91.7% | Reduced |
| GAMMA Investing LLC | 94 | $2.78K | 0.00% | +14+17.5% | Added |
| Federated Hermes, Inc. | 60 | $1.77K | 0.00% | +60 | New |
| Nisa Investment Advisors, LLC | 7 | $207 | 0.00% | +7 | New |
| Russell Investments Group, Ltd. | 7 | $207 | 0.00% | +7 | New |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 2 | $59 | 0.00% | +2 | New |
| CWM, LLC | 1 | $0 | 0.00% | +1 | New |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −143,235−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −103,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −9,433−100.0% | Sold out |
| Golden State Equity Partners | – | – | – | – | Not filed |